EUVIMEDEUVIMED entdecken
Open Access

Design and Synthesis of Benzofuran‐1,4‐dihydropyridine Hybrids as Novel Anti‐Inflammatory Agents: Theoretical Exploration of a Potential Dual COX‐2/TNF‐α Mechanism

Katia Mohand Saidi iD, Bassam A Najri, Smail Khelili iD, Kamel Harrouche, Mohamed Zakaria Stiti iD, Elyes Kelai, Abdelmadjid Guendouzi, Tahir Habila, Arif Kivrak

Chemistry & Biodiversity · 2026-05 · 23 (5)

DOI: 10.1002/cbdv.202503119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 13.05.2026. Verfasst von Katia Mohand Saidi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Exact Sciences and Informatics, University of Mohamed Seddik Ben Yahia-Jijel, Ouled Aissa, Algeria. Hauptthemen laut MEDLINE: Cyclooxygenase 2, Benzofurans, Dihydropyridines, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Algerian Ministry of Higher Education and Scientific Research, Directorate General for Scientific Research and Technological Development, Direction Générale de la Recherche Scientifique et du Développement Technologique.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This research presents the design, synthesis, and thorough evaluation of a new series of benzofuran‐1,4‐dihydropyridine hybrids ( 4a–i ) as potential multi‐target anti‐inflammatory drugs. These compounds were created through an optimized multistep process and examined using a combination of in silico, in vitro, and in vivo methods. Molecular docking revealed a potential dual‐target profile, with the leading compounds showing strong predicted binding to both COX‐2 and TNF‐α. Notably, compound 4i demonstrated the highest affinity for COX‐2 (MolDock score = −181.002 kcal/mol), with good selectivity over COX‐1 (Δ = −21.35), and also showed one of the strongest affinities for TNF‐α (−174.847 kcal/mol). Molecular dynamics simulations confirmed the stability of the 4i ‐COX‐2 complex. This in silico effectiveness was supported by strong in vitro anti‐inflammatory activity (eg. 10.09 µg/mL for IC 50 of 4b in hypotonicity‐induced hemolysis). Notably, the compounds showed excellent in vivo activity in a carrageenan‐induced paw edema model, with 4i achieving 91.5% inhibition at 90 min. Histological analysis confirmed that the lead compounds were highly gastrointestinal (GI)‐sparing, consistent with their predicted COX‐2 selectivity. No liver damage was observed, and platelet count remained normal ( 4i ). Overall, this study identifies compound 4i as a potent, orally active, and safe antinflammatory candidate with potential dual mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclooxygenase 2BenzofuransDihydropyridinesTumor Necrosis Factor-alphaDrug DesignAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 InhibitorsAnti-Inflammatory AgentsAnimalsEdemaMolecular Docking SimulationCarrageenanStructure-Activity RelationshipHumansRatsMolecular StructureMolecular Dynamics SimulationCyclooxygenase 1MaleMiceDose-Response Relationship, Drug

Stichwörter der Autor:innen

ADMETanti‐inflammatory activitybenzofuran‐1,4‐dihydropyridine hybridsgastrointestinal safetymolecular docking and molecular dynamics

Substanzen

Cyclooxygenase 2BenzofuransDihydropyridinesTumor Necrosis Factor-alphaAnti-Inflammatory Agents, Non-SteroidalCarrageenanCyclooxygenase 2 Inhibitors1,4-dihydropyridineAnti-Inflammatory AgentsCyclooxygenase 1

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Exact Sciences and Informatics, University of Mohamed Seddik Ben Yahia-Jijel, Ouled Aissa, Algeria.
  • Pharmaceutical Team Laboratory of Phytochemistry and Pharmacology, University of Mohamed Seddik Ben Yahia-Jijel, Ouled Aissa, Algeria.
  • Department of Chemistry, Faculty of Sciences, Eskisehir Osmangazi University, Eskisehir, Turkey.
  • Centre De Recherche Scientifique Et Technique En Analyses Physico-Chimiques (CRAPC), Tipaza, Algeria.
  • Chemistry Laboratory: Synthesis, Properties and Applications (LCSPA), University of Saida, Saida, Algeria.
  • Department of Physical Sciences, Higher Normal School of Boussada, Msila, Algeria.

ORCID-Profile: Katia Mohand Saidi, Smail Khelili, Mohamed Zakaria Stiti

Förderung

  • Algerian Ministry of Higher Education and Scientific Research
  • Directorate General for Scientific Research and Technological Development
  • Direction Générale de la Recherche Scientifique et du Développement Technologique

Zitieren

APA

Saidi, K. M., Najri, B. A., Khelili, S., Harrouche, K., Stiti, M. Z., Kelai, E., Guendouzi, A., Habila, T., & Kivrak, A. (2026). Design and Synthesis of Benzofuran‐1,4‐dihydropyridine Hybrids as Novel Anti‐Inflammatory Agents: Theoretical Exploration of a Potential Dual COX‐2/TNF‐α Mechanism. Chemistry & Biodiversity, 23(5). https://doi.org/10.1002/cbdv.202503119

Vancouver

Saidi KM, Najri BA, Khelili S, Harrouche K, Stiti MZ, Kelai E, et al. Design and Synthesis of Benzofuran‐1,4‐dihydropyridine Hybrids as Novel Anti‐Inflammatory Agents: Theoretical Exploration of a Potential Dual COX‐2/TNF‐α Mechanism. Chemistry & Biodiversity. 2026;23(5). doi:10.1002/cbdv.202503119

BibTeX
@article{Saidi2026,
  author = {Saidi, Katia Mohand and Najri, Bassam A and Khelili, Smail and Harrouche, Kamel and Stiti, Mohamed Zakaria and Kelai, Elyes and Guendouzi, Abdelmadjid and Habila, Tahir and Kivrak, Arif},
  title = {Design and Synthesis of Benzofuran‐1,4‐dihydropyridine Hybrids as Novel Anti‐Inflammatory Agents: Theoretical Exploration of a Potential Dual COX‐2/TNF‐α Mechanism},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {5},
  doi = {10.1002/cbdv.202503119}
}
Kostenlos starten →